Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock		Capital in Excess of Par Value		Retained earnings		Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss) Income		Accumulated Other Comprehensive (Loss) Income Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (in shares) at Nov. 03, 2018	[1]		370,160
Beginning Balance at Nov. 03, 2018			$ 61,694	[1]	$ 5,282,222	[1]	$ 5,982,697	[1]	$ 331,026	$ (58,440)	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	[1]						1,363,011
Dividends declared and paid							(777,481)
Issuance of stock under stock plans and other (in shares)			4,271
Issuance of stock under stock plans and other			$ 712		115,811
Stock-based compensation expense					150,300
Other comprehensive Income (loss)										(129,359)
Common stock repurchased (in shares)			(6,129)
Common stock repurchased			$ (1,021)		(611,984)
Ending Balance (in shares) at Nov. 02, 2019			368,302
Ending Balance at Nov. 02, 2019			$ 61,385		4,936,349		6,899,253		$ 2,379	(187,799)		$ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income							1,220,761
Dividends declared and paid							(886,155)
Issuance of stock under stock plans and other (in shares)			3,110
Issuance of stock under stock plans and other			$ 518		67,885
Issuance of stock as charitable contribution (in shares)			336
Issuance of stock as charitable contribution			$ 56		39,944
Stock-based compensation expense					149,518
Other comprehensive Income (loss)										(59,283)
Common stock repurchased (in shares)			(2,263)
Common stock repurchased			$ (377)		(244,110)
Ending Balance (in shares) at Oct. 31, 2020			369,485
Ending Balance at Oct. 31, 2020		$ 11,997,945	$ 61,582		4,949,586		7,236,238			(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income							1,390,422
Dividends declared and paid							(1,109,344)
Issuance of stock under stock plans and other (in shares)			2,738
Issuance of stock under stock plans and other			$ 355		62,750
Issuance of stock in connection with acquisition (in shares)			169,233
Issuance of stock in connection with the Acquisition			$ 28,204		27,725,957
Stock-based compensation expense					243,611
Replacement share-based awards issued in connection with the Acquisition					194,890
Other comprehensive Income (loss)										62,896
Common stock repurchased (in shares)			(16,125)
Common stock repurchased			$ (2,587)		(2,602,557)
Ending Balance (in shares) at Oct. 30, 2021			525,331
Ending Balance at Oct. 30, 2021		$ 37,992,542	$ 87,554		$ 30,574,237		$ 7,517,316			$ (186,565)

[1] Balances have been restated to reflect the adoption of Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (ASU 2014-09). See Note 2a, Principles of Consolidation, of the Notes to Consolidated Financial Statements.